Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs

Vaccine

Volumn 31, Issue 24, 2013, Pages 2692-2697

  Donauer, Stephanie ^a   Payne, Daniel C ^b   Edwards, Kathryn M ^c   Szilagyi, Peter G ^d   Hornung, Richard W ^a   Weinberg, Geoffrey A ^d   Chappell, James ^c   Hall, Caroline B ^d   Parashar, Umesh D ^b   Staat, Mary Allen ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Case cohort studies; Case control studies; Immunization; Rotavirus; Rotavirus vaccines; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CALCULATION; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; EMERGENCY WARD; FEMALE; GENOTYPE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROTAVIRUS; ROTAVIRUS INFECTION; SEASON; SEROTYPE; SINGLE DRUG DOSE; STUDY DESIGN;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; MALE; NEW YORK; OHIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TENNESSEE; VACCINES, ATTENUATED;

EID: 84878368204     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.03.072     Document Type: Article

References (51)

1. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9(May (5)):565-572.
2. Fischer T.K., Viboud C., Parashar U., Malek M., Steiner C., Glass R., et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007, 195(April (8)):1117-1125.
3. Parashar U.D., Holman R.C., Clarke M.J., Bresee J.S., Glass R.I. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J Infect Dis 1998, 177(January (1)):13-17.
4. Charles M.D., Holman R.C., Curns A.T., Parashar U.D., Glass R.I., Bresee J.S. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J 2006, 25(June (6)):489-493.
5. Malek M.A., Curns A.T., Holman R.C., Fischer T.K., Bresee J.S., Glass R.I., et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006, 117(June (6)):1887-1892.
6. Tate J.E., Cortese M.M., Payne D.C., Curns A.T., Yen C., Esposito D.H., et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011, 30(January (Suppl. 1)):S56-S60.
7. Staat M.A., Rice M.A., Donauer S., Payne D.C., Bresee J.S., Mast T.C., et al. Estimating the rotavirus hospitalization disease burden and trends, using capture-recapture methods. Pediatr Infect Dis J 2010, 29(December (12)):1083-1086.
8. Tate J.E., Mutuc J.D., Panozzo C.A., Payne D.C., Cortese M.M., Cortes J.E., et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011, 30(January (Suppl. 1)):S30-S34.
9. Yen C., Tate J.E., Wenk J.D., Harris J.M., Parashar U.D. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011, 127(January (1)):e9-e15.
10. Reduction in rotavirus after vaccine introduction - United States, 2000-2009. MMWR - Morbidity and mortality weekly report. 2009;58(October (41)):1146-9.
11. Payne D.C., Staat M.A., Edwards K.M., Szilagyi P.G., Weinberg G.A., Hall C.B., et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009. Clin Infect Dis 2011, 53(August (3)):245-253.
12. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007-May 2008. MMWR - Morbidity and mortality weekly report 2008;57(June (25)):697-700.
13. Parashar U.D., Alexander J.P., Glass R.I. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(August (RR-12)):1-13.
14. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 2007;119(January (1)):171-82.
15. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009;123(May (5)):1412-20.
16. Orenstein W.A., Bernier R.H., Hinman A.R. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988, 10:212-241.
17. Eisenberg K.W., Szilagyi P.G., Fairbrother G., Griffin M.R., Staat M., Shone L.P., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122(November (5)):911-919.
18. Jick H., Hagberg K.W. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines. Vaccine 2010, 28(June (29)):4588-4592.
19. Harling R., White J.M., Ramsay M.E., Macsween K.F., van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005, 23(July (31)):4070-4074.
20. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368(October (9546)):1495-1502.
21. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Hull J.J., Gentsch J.R., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125(February (2)):e199-e207.
22. Guh A.Y., Hadler J.L. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. Vaccine 2011, 29(August (37)):6155-6158.
23. Staat M.A., Payne D.C., Donauer S., Weinberg G.A., Edwards K.M., Szilagyi P.G., et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011, 128(August (2)):e267-e275.
24. Bisgard K.M., Rhodes P., Connelly B.L., Bi D., Hahn C., Patrick S., et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005, 116(August (2)):e285-e294.
25. Breslow N.E. Statistics in epidemiology: the case-control study. Journal of the American Statistical Association 1996, 91(March (433)):14-28.
26. Gilca R., Deceuninck G., De Serres G., Boulianne N., Sauvageau C., Quach C., et al. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics 2011, 128(November (5)):e1084-e1091.
27. Cortese M.M., Leblanc J., White K.E., Jerris R.C., Stinchfield P., Preston K.L., et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics 2011, 128(December (6)):e1474-e1481.
28. Kalies H., Verstraeten T., Grote V., Meyer N., Siedler A., Schmitt H.J., et al. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. Pediatr Infect Dis J 2004, 23(October (10)):944-950.
29. Kalies H., Grote V., Siedler A., Grondahl B., Schmitt H.J., von Kries R. Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure. Vaccine 2008, 26(May (20)):2545-2552.
30. Szilagyi P.G., Fairbrother G., Griffin M.R., Hornung R.W., Donauer S., Morrow A., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 2008, 162(October (10)):943-951.
31. Moulton L.H., Chung S., Croll J., Reid R., Weatherholtz R.C., Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol 2000, 29(August (4)):753-756.
32. Prentice R. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986, 73(1):1-11.
33. Thompson M., Williams J., Naleway A., Li D.K., Chu S., Bozeman S., et al. The pregnancy and influenza project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants. Am J Obstet Gynecol 2011, 204(June (6 Suppl. 1)):S69-S76.
34. Payne D.C., Staat M.A., Edwards K.M., Szilagyi P.G., Gentsch J.R., Stockman L.J., et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008, 122(December (6)):1235-1243.
35. Payne D.C., Szilagyi P.G., Staat M.A., Edwards K.M., Gentsch J.R., Weinberg G.A., et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J 2009, 28(November (11)):948-953.
36. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990, 28(February (2)):276-282.
37. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992, 30(June (6)):1365-1373.
38. Griffin D.D., Nakagomi T., Hoshino Y., Nakagomi O., Kirkwood C.D., Parashar U.D., et al. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses. Virology 2002, 294(March (2)):256-269.
39. Das B.K., Gentsch J.R., Cicirello H.G., Woods P.A., Gupta A., Ramachandran M., et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994, 32(July (7)):1820-1822.
40. Levy P.S., Lemeshow S. Sampling of populations methods and applications 1999, John Wiley, New York, NY, 520 pp. 3rd ed.
41. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355(July (1)):31-40.
42. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342(January (4)):225-231.
43. Iwane M.K., Edwards K.M., Szilagyi P.G., Walker F.J., Griffin M.R., Weinberg G.A., et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113(June (6)):1758-1764.
44. Binder D.A. Fitting Cox's proportional hazards models from survey data. Biometrika Trust 1992, 79:139-147.
45. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
46. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Quaye O., Mijatovic-Rustempasic S., et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010, 29(December (12)):1133-1135.
47. Weinberg G.A., Szilagyi P.G. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis 2010, 201(June (11)):1607-1610.
48. Moulton L.H., Wolff M.C., Brenneman G., Santosham M. Case-cohort analysis of case-coverage studies of vaccine effectiveness. Am J Epidemiol 1995, 142(November (9)):1000-1006.
49. Smith P.J., Chu S.Y., Barker L.E. Children who have received no vaccines: who are they and where do they live?. Pediatrics 2004, 114(July (1)):187-195.
50. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009. MMWR - Morbidity and mortality weekly report 2010;59(May (17)):521-4.
51. Dennehy P.H., Gauntlett D.R., Spangenberger S.E. Choice of reference assay for the detection of rotavirus in fecal specimens: electron microscopy versus enzyme immunoassay. J Clin Microbiol 1990, 28(June (6)):1280-1283.